Assessing the OPRA trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancer is a research paper published in Surgical Oncology Insight (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: T32CA009501\u201331A1
NIH
Grant: R3712873049
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: T32 CA009501
FWCI
0.70
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals